| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |